Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
10 years of interferon beta-1b (Beta feron therapy.
Effect of therapeutic horseback riding on balance and gait of people with multiple sclerosis.
Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.
In vivo and in vitro effects of multiple sclerosis immunomodulatory therapeutics on glutamatergic excitotoxicity.
Multiple Sclerosis: An Update.
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Myelin injury induces axonal transport impairment but not AD-like pathology in the hippocampus of cuprizone-fed mice.
Neurorehabilitation Topics in Patients with Multiple Sclerosis: From Outcome Measurements to Rehabilitation Interventions.
Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression.
Interferon-beta1b for the treatment of multiple sclerosis.
Hydrogen-rich water improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.
TECFIDERA® (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy for Newly-Diagnosed MS Patients
Imidazol-1-ylethylindazole voltage-gated sodium channel ligands are neuroprotective during optic neuritis in a mouse model of multiple sclerosis.
Neurovascular coupling in patients with relapsing-remitting multiple sclerosis.
Cervical cord and ventricle affection in neuromyelitis optica.
Factors in Patient Empowerment: A Survey of an Online Patient Research Network.
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.
Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
Recent insights into the mechanism of action of glatiramer acetate.
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
Pages
« first
‹ previous
…
71
72
73
74
75
76
77
78
79
…
next ›
last »